Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07167381 · ClinicalTrials.gov registry record · NA

xDRIVE for Florida-based Cancer Patients

A NA study of Cancer and Lymphoma, sponsored by First Ascent Biomedical.

Recruiting
Registry status
NA
Development phase
210
Enrollment target
2
Study locations

NCT07167381 is a NA study of Cancer and Lymphoma that is actively recruiting participants, run by First Ascent Biomedical. The registered enrollment target is 210 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07167381, a NA study of Cancer and Lymphoma, is actively recruiting participants, sponsored by First Ascent Biomedical.

RECRUITING
Registry status
NA
Development phase
210 participants
Enrollment target
2
Study locations

Study Summary

Through this study funded by the Florida Cancer Innovation Fund, First Ascent will demonstrate state-wide feasibility of providing xDRIVE Functional Precision Medicine + Artificial Intelligence platform by assessing patient clinical benefit and health economics impacts. As this is a feasibility study, results will be returned to the physician and the physician may use the data to inform the next line of treatment. The investigator will run a prospective single-arm feasibility study providing the xDRIVE FPM AI platform to n = 210+ cancer patients throughout the state of Florida, especially those from underserved populations (pediatric patients and patients in Black, Brown, Hispanic, and rural communities).

Conditions Studied

Cancer Lymphoma Solid Tumor Malignancies Recurrence Refractory Solid Cancers Neoplams Leukaemia

Interventions

  • DIAGNOSTIC_TEST xDRIVE Tumor Profiling

Study Locations (2)

Florida

  • First Ascent Biomedical - Miami
  • Florida International University - Miami

Trial Details

FieldValue
Enrollment Target 210 participants
Start Date 2025-11-01
Est. Completion 2027-04-01
Phase NA

Sponsor

First Ascent Biomedical

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07167381

The ClinicalTrials.gov registry entry for NCT07167381 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The listed sponsor is First Ascent Biomedical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which xDRIVE Tumor Profiling is the first listed.

NCT07167381 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07167381 about?

NCT07167381 is a clinical study titled "xDRIVE for Florida-based Cancer Patients". Through this study funded by the Florida Cancer Innovation Fund, First Ascent will demonstrate state-wide feasibility of providing xDRIVE Functional Precision Medicine + Artificial Intelligence platform by assessing patient clinical benefit and health economics impacts. As this is a feasibility stud...

What is the current status of trial NCT07167381?

This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2025-11-01. Estimated completion is 2027-04-01.

What conditions does trial NCT07167381 study?

This clinical trial studies the following conditions: Cancer, Lymphoma, Solid Tumor Malignancies, Recurrence, Refractory.

What interventions are being tested in trial NCT07167381?

The interventions under investigation include: xDRIVE Tumor Profiling (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07167381?

This trial is sponsored by First Ascent Biomedical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07167381 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

Lymphoma

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.